These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8898050)

  • 41. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.
    Ruzicka T; Bieber T; Schöpf E; Rubins A; Dobozy A; Bos JD; Jablonska S; Ahmed I; Thestrup-Pedersen K; Daniel F; Finzi A; Reitamo S
    N Engl J Med; 1997 Sep; 337(12):816-21. PubMed ID: 9295241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis.
    McCollum AD; Paik A; Eichenfield LF
    Pediatr Dermatol; 2010; 27(5):425-36. PubMed ID: 20678096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Open-label, pilot study examining sequential therapy with oral tacrolimus and topical tacrolimus for severe atopic dermatitis.
    Keaney TC; Bhutani T; Sivanesan P; Bandow GD; Weinstein SB; Cheung LC; Malick F; Koo J
    J Am Acad Dermatol; 2012 Oct; 67(4):636-41. PubMed ID: 22221776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis.
    Reitamo S; Mandelin J; Rubins A; Remitz A; Mäkelä M; Cirule K; Rubins S; Zigure S; Ho V; Dickinson J; Undre N
    Int J Dermatol; 2009 Apr; 48(4):348-55. PubMed ID: 19335418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis.
    Hebert AA; Koo J; Fowler J; Berman B; Rosenberg C; Levitt J
    Cutis; 2006 Nov; 78(5):357-63. PubMed ID: 17186796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Topical immune modulation and risk of cancer].
    Deleuran M; Zachariae C; Thestrup-Pedersen K
    Ugeskr Laeger; 2009 Aug; 171(35):2468-71. PubMed ID: 19732533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical tacrolimus in the management of atopic dermatitis in Japan.
    Furue M; Uchi H; Moroi Y; Ogawa S; Nakahara T; Urabe K
    Dermatol Ther; 2006; 19(2):118-26. PubMed ID: 16669995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
    Ingram JR; Martin JA; Finlay AY
    Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tacrolimus ointment: a new therapy for atopic dermatitis--review of the literature.
    Pustisek N; Lipozencić J; Ljubojević S
    Acta Dermatovenerol Croat; 2002 Mar; 10(1):25-32. PubMed ID: 12137728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1 year.
    Van Leent EJ; De Vries HJ; Ebelin ME; Burtin P; Scott G; Bos JD
    J Dermatolog Treat; 2007; 18(1):19-22. PubMed ID: 17365262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Viewpoint of the German Dermatologic Society (DDG) concerning the decision of the American Food and Drug Administration (FDA) on the use of pimecrolimus cream and tacrolimus ointment in the treatment of atopic dermatitis (neurodermatitis)].
    Luger TA; Gollnick H
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):415-6. PubMed ID: 15892843
    [No Abstract]   [Full Text] [Related]  

  • 52. Topical tacrolimus and pimecrolimus: future directions.
    Ling MR
    Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A; Reitamo S; Girolomoni G; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
    Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial.
    Mandelin J; Remitz A; Virtanen H; Reitamo S
    Acta Derm Venereol; 2010 Mar; 90(2):170-4. PubMed ID: 20169301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.
    Dähnhardt-Pfeiffer S; Dähnhardt D; Buchner M; Walter K; Proksch E; Fölster-Holst R
    J Dtsch Dermatol Ges; 2013 May; 11(5):437-43. PubMed ID: 23551950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T; Kapp A; Spergel J
    Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
    Naylor M; Elmets C; Jaracz E; Rico JM
    J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.